Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is ...

Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...

Tandem Diabetes (TNDM) stock jumps as Piper Sandler upgrades the company arguing that its pay-as-you-go pharmacy model could ...

Please provide your email address to receive an email when new articles are posted on . Portal Pump is an investigational implantable device that delivers insulin directly to the peritoneal space. The ...

Portal Diabetes has received the US Food and Drug Administration (FDA) breakthrough device designation for its implantable insulin pump system, known as the Portal Pump. It has also initiated a Phase ...

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable ...

Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.

In March 2026, Tandem Diabetes Care announced that its Tandem Mobi automated insulin delivery system can now be controlled ...

An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 ...

Tandem Diabetes Care (NasdaqGM:TNDM) has enabled compatibility of its Tandem Mobi automated insulin delivery system with ...

The Flex pump worn at the hip. [Image courtesy of MiniMed] MiniMed (Nasdaq:MMED) announced today that it received FDA clearance for the MiniMed Flex next-generation insulin pump. Flex, a discreet, ...

Westfield-based Portal Diabetes Inc. announced Tuesday that the U.S. Food and Drug Administration provided the company with a breakthrough device designation for its implantable insulin pump system.